Merck & Co. is caught in the middle of Wall Street's version of a group chat disagreement. Analysts gave it a “Moderate Buy” ...

UnitedHealth Group saw its price target slashed from $640 to $510 by Robert W. Baird, despite maintaining an “outperform” ...

Amazon has responded to tariff concerns by leaning on its third-party sellers, who bulked up inventory to maintain pricing ...

Tesla’s European joyride is skidding hard in April, with sales nose-diving across key markets like Sweden, Denmark, and ...

Eli Lilly’s Q1 earnings smashed expectations, fueled by surging demand for its blockbuster drugs Zepbound and Mounjaro. The ...

Southern Copper just got a lukewarm upgrade from HSBC Global Res, shifting from “moderate sell” to “hold”—which is basically ...

California State Teachers Retirement System reduced its Exxon Mobil holdings by 9.1% in Q4, selling 532,382 shares, yet it ...

JPMorgan Chase strutted into Q1 2025 with a financial performance that deserves a standing ovation and maybe a bonus or two.

Alphabet, despite a tech giant glow-up, has underperformed the broader market, dropping 16.1% year-to-date while others ...

Apple shares dipped nearly 3% after CEO Tim Cook revealed a looming $900 million tariff toll this quarter and scaled down ...

AMD is preparing to report its Q1 2025 earnings with strong expectations: $0.94 EPS and $7.12 billion in revenue. Analyst Jay ...

Walmart saw a small trim in its holdings by Beacon Pointe Advisors, who offloaded 22,795 shares in Q4, though the retailer ...